EPIDEMIOLOGICAL PROFILE OF SKIN CANCER IN BRAZIL, FROM 2019 TO 2023.
DOI:
https://doi.org/10.36557/pbpc.v3i2.156Keywords:
Epidemiology, Skin neoplasms, Melanoma, Non-melanomaAbstract
INTRODUCTION: In Brazil, skin cancer is the most common, accounting for about 30% of all malignant tumors recorded. The non-melanoma type, which includes basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), is the most prevalent and has the lowest mortality rate. These tumors have low lethality and rare metastases. Skin cancer most often affects people with fair skin, weakened immune systems, and radiation exposure. Melanoma is the least common type of skin cancer, but it has the worst prognosis and the highest mortality rate among malignant skin neoplasms. It is associated with a personal or family history of melanoma and intense sunburn in multiple episodes. METHODOLOGY: This is an epidemiological, retrospective, and descriptive research, with a quantitative approach, based on data obtained from the Department of Informatics of the Unified Health System (DATASUS), carried out using data on skin cancer notifications in Brazil between the years 2019 and 2023. RESULT AND DISCUSSION: Between 2019 and 2023, 399,230 cases of skin cancer were registered in Brazil, with 46.1% of cases in men (184,515) and 53.9% in women (214,715). The discrepancy between the sexes can be attributed to behavioral, biological, and socioeconomic factors, including the influence of female hormones, such as estrogen, on cutaneous carcinogenesis. Most cases were of other malignant skin neoplasms (74.22%), followed by carcinoma in situ (18.85%) and malignant melanoma (6.93%). The Southeast region was the most affected, with 41.29% (165,105 cases), followed by the South with 35.61% (142,043 cases). The Northeast, Midwest and North regions had 12.91% (51,558 cases), 6.42% (25,608 cases) and 3.74% (14,916 cases) respectively. The incidence by age group shows that people over 60 years old are the most affected. Specifically, the age groups between 60 and 64 years accounted for 12.06% (48,167 cases), between 65 and 69 years 13.22% (52,723 cases), between 70 and 74 years 12.89% (51,398 cases), between 75 and 79 years 10.87% (43,429 cases) and 80 years and over 15.47% (61,786 cases). CONCLUSION: It is concluded that women were more affected by skin cancer and the Southeast region had a higher number of cases. The age group over 60 years was most affected and malignant skin neoplasms accounted for the majority of cases. Between 2019 and 2023, there was a significant increase in incidence. The combination of behavioral, biological, and regional factors, sun exposure, hormonal influence, and variations in population density and access to health care reflect this increase in cases.
References
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. Gender differences in skin cancer incidence and awareness: A review. American Journal of Clinical Dermatology, 2020.
Barreiro G, Zanella F A, Rosa KGD, Calvett R, Senandes LS, Vizzotto MD, et al. O impacto de ações assistenciais na percepção da qualidade do Sistema Único de Saúde (SUS), Brasil: um estudo transversal. Rev Bras Cir Plást. 2016;31(2):242-5.
BERTOLDI MB, Bastos CAS, Sampaio CL. Melanoma Cutâneo em um Hospital Universitário, 2001-2016. Revista Brasileira de Cancerologia. 2020; 66(3).
DA SILVA, R. D., & Dias, M. A. I. (2017). Incidência do carcinoma basocelular e espinocelular em usuários atendidos em um hospital de câncer. Revista Família, Ciclos de Vida e Saúde no Contexto Social, 5(2), 228-234.
DARIVA A, Rodrigues F. Neoplasias Malignas de Pele. Escola de Medicina da PUCRS.2018
DERMATOLOGY RESEARCH AND PRACTICE. Sun exposure and skin cancer risk: A systematic review and meta-analysis. Dermatology Research and Practice, 2018.
FERREIRA FR, Nascimento LFC, Rotta O. Fatores de risco para câncer da pele não melanoma em Taubaté, SP: um estudo caso-controle. Rev. Assoc. Med. Bras. 2011;57(4):431-437.
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) (2020). Ministério da Saúde.
JOURNAL OF INVESTIGATIVE DERMATOLOGY. Hormonal influences on skin cancer: The role of estrogen and other hormones. Journal of Investigative Dermatology, 2019.
TREJIĆ, S. et al. Diagnostic Accuracy of Skin Cancer by Family Physicians. The Journal of the American Board of Family Medicine, v. 34, n. 5, p. 984–990, set. 2021.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Maria Gabryella Pereira da Silva Camarço, Talya Aguiar de Lima, Millena Guedes Caland Brigido , Jakson Francisco Rodrigues Sena, Janaína Mendes Caldas Sampaio, Maria Clara Neiva de Alencar, Maria Clara Barbosa de Almeida, Emília Moura Silva, Ana Raquel Cordeiro Rodrigues Monte, Thallyta Hellen Soares da Silva , Elmar Caland Brígido
This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
- Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
- Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
- O licenciante não pode revogar estes direitos desde que você respeite os termos da licença.
De acordo com os termos seguintes:
- Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.